A prospective international multi-center study on safety and efficacy of deep brain stimulation for resistant obsessive-compulsive disorder

Deep brain stimulation (DBS) has been proposed for severe, chronic, treatment-refractory obsessive-compulsive disorder (OCD) patients. Although serious adverse events can occur, only a few studies report on the safety profile of DBS for psychiatric disorders. In a prospective, open-label, interventi...

ver descrição completa

Detalhes bibliográficos
Autores: Menchón Magriñá, José Manuel, Real, Eva, Alonso, Pino, Aparicio, Marco Alberto, Segalàs Cosi, Cinto, Plans, Gerard, Luyten, Laura, Brunfaut, Els, Matthijs, Laurean, Raymakers, Simon, Bervoets, Chris, Higueras, Antonio, Katati, Majed, Guerrero, José, Hurtado, Mariena, Prieto, Mercedes, Stieglitz, Lennart H., Löffelholz, Georg, Walther, Sebastian, Pollo, Claudio, Zurowski, Bartosz, Tronnier, Volker, Kordon, Andreas, Gambini, Orsola, Ranieri, Rebecca, Franzini, Angelo, Messina, Giuseppe, Radu Djurfeldt, Diana, Schechtmann, Gaston, Chen, Long-Long, Eitan, Renata, Israel, Zvi, Bergman, Hagai, Brelje, Tim, Brionne, Thomas C., Conseil, Aurélie, Gielen, Frans, Schuepbach, Michael, Nuttin, Bart, Gabriëls, Loes
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2019
País:España
Recursos:Universidad de Barcelona
Repositorio:Dipòsit Digital de la UB
OAI Identifier:oai:diposit.ub.edu:2445/176452
Acesso em linha:https://hdl.handle.net/2445/176452
Access Level:acceso abierto
Palavra-chave:Neurosi obsessiva
Estimulació del cervell
Seguretat dels pacients
Obsessive-compulsive disorder
Brain stimulation
Patients safety
id ES_a3fd2e80ddd0301b00f716a4d4eb3bbf
oai_identifier_str oai:diposit.ub.edu:2445/176452
network_acronym_str ES
network_name_str España
repository_id_str
spelling A prospective international multi-center study on safety and efficacy of deep brain stimulation for resistant obsessive-compulsive disorderMenchón Magriñá, José ManuelReal, EvaAlonso, PinoAparicio, Marco AlbertoSegalàs Cosi, CintoPlans, GerardLuyten, LauraBrunfaut, ElsMatthijs, LaureanRaymakers, SimonBervoets, ChrisHigueras, AntonioKatati, MajedGuerrero, JoséHurtado, MarienaPrieto, MercedesStieglitz, Lennart H.Löffelholz, GeorgWalther, SebastianPollo, ClaudioZurowski, BartoszTronnier, VolkerKordon, AndreasGambini, OrsolaRanieri, RebeccaFranzini, AngeloMessina, GiuseppeRadu Djurfeldt, DianaSchechtmann, GastonChen, Long-LongEitan, RenataIsrael, ZviBergman, HagaiBrelje, TimBrionne, Thomas C.Conseil, AurélieGielen, FransSchuepbach, MichaelNuttin, BartGabriëls, LoesNeurosi obsessivaEstimulació del cervellSeguretat dels pacientsObsessive-compulsive disorderBrain stimulationPatients safetyDeep brain stimulation (DBS) has been proposed for severe, chronic, treatment-refractory obsessive-compulsive disorder (OCD) patients. Although serious adverse events can occur, only a few studies report on the safety profile of DBS for psychiatric disorders. In a prospective, open-label, interventional multi-center study, we examined the safety and efficacy of electrical stimulation in 30 patients with DBS electrodes bilaterally implanted in the anterior limb of the internal capsule. Safety, efficacy, and functionality assessments were performed at 3, 6, and 12 months post implant. An independent Clinical Events Committee classified and coded all adverse events (AEs) according to EN ISO14155:2011. All patients experienced AEs (195 in total), with the majority of these being mild (52% of all AEs) or moderate (37%). Median time to resolution was 22 days for all AEs and the etiology with the highest AE incidence was 'programming/stimulation' (in 26 patients), followed by 'New illness, injury, condition' (13 patients) and 'pre-existing condition, worsening or exacerbation' (11 patients). Sixteen patients reported a total of 36 serious AEs (eight of them in one single patient), mainly transient anxiety and affective symptoms worsening (20 SAEs). Regarding efficacy measures, Y-BOCS reduction was 42% at 12 months and the responder rate was 60%. Improvements in GAF, CGI, and EuroQol-5D index scores were also observed. In sum, although some severe AEs occurred, most AEs were mild or moderate, transient and related to programming/stimulation and tended to resolve by adjustment of stimulation. In a severely treatment-resistant population, this open-label study supports that the potential benefits outweigh the potential risks of DBS.Nature Publishing Group2019info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://hdl.handle.net/2445/176452Articles publicats en revistes (Ciències Clíniques)reponame:Dipòsit Digital de la UBinstname:Universidad de BarcelonaInglésReproducció del document publicat a: https://doi.org/10.1038/s41380-019-0562-6Molecular Psychiatry, 2019, vol. 26, p. 1234-1247https://doi.org/10.1038/s41380-019-0562-6cc by (c) Menchón Magriñá, José Manuel et al., 2019http://creativecommons.org/licenses/by/3.0/es/info:eu-repo/semantics/openAccessoai:diposit.ub.edu:2445/1764522026-05-27T06:46:51Z
dc.title.none.fl_str_mv A prospective international multi-center study on safety and efficacy of deep brain stimulation for resistant obsessive-compulsive disorder
title A prospective international multi-center study on safety and efficacy of deep brain stimulation for resistant obsessive-compulsive disorder
spellingShingle A prospective international multi-center study on safety and efficacy of deep brain stimulation for resistant obsessive-compulsive disorder
Menchón Magriñá, José Manuel
Neurosi obsessiva
Estimulació del cervell
Seguretat dels pacients
Obsessive-compulsive disorder
Brain stimulation
Patients safety
title_short A prospective international multi-center study on safety and efficacy of deep brain stimulation for resistant obsessive-compulsive disorder
title_full A prospective international multi-center study on safety and efficacy of deep brain stimulation for resistant obsessive-compulsive disorder
title_fullStr A prospective international multi-center study on safety and efficacy of deep brain stimulation for resistant obsessive-compulsive disorder
title_full_unstemmed A prospective international multi-center study on safety and efficacy of deep brain stimulation for resistant obsessive-compulsive disorder
title_sort A prospective international multi-center study on safety and efficacy of deep brain stimulation for resistant obsessive-compulsive disorder
dc.creator.none.fl_str_mv Menchón Magriñá, José Manuel
Real, Eva
Alonso, Pino
Aparicio, Marco Alberto
Segalàs Cosi, Cinto
Plans, Gerard
Luyten, Laura
Brunfaut, Els
Matthijs, Laurean
Raymakers, Simon
Bervoets, Chris
Higueras, Antonio
Katati, Majed
Guerrero, José
Hurtado, Mariena
Prieto, Mercedes
Stieglitz, Lennart H.
Löffelholz, Georg
Walther, Sebastian
Pollo, Claudio
Zurowski, Bartosz
Tronnier, Volker
Kordon, Andreas
Gambini, Orsola
Ranieri, Rebecca
Franzini, Angelo
Messina, Giuseppe
Radu Djurfeldt, Diana
Schechtmann, Gaston
Chen, Long-Long
Eitan, Renata
Israel, Zvi
Bergman, Hagai
Brelje, Tim
Brionne, Thomas C.
Conseil, Aurélie
Gielen, Frans
Schuepbach, Michael
Nuttin, Bart
Gabriëls, Loes
author Menchón Magriñá, José Manuel
author_facet Menchón Magriñá, José Manuel
Real, Eva
Alonso, Pino
Aparicio, Marco Alberto
Segalàs Cosi, Cinto
Plans, Gerard
Luyten, Laura
Brunfaut, Els
Matthijs, Laurean
Raymakers, Simon
Bervoets, Chris
Higueras, Antonio
Katati, Majed
Guerrero, José
Hurtado, Mariena
Prieto, Mercedes
Stieglitz, Lennart H.
Löffelholz, Georg
Walther, Sebastian
Pollo, Claudio
Zurowski, Bartosz
Tronnier, Volker
Kordon, Andreas
Gambini, Orsola
Ranieri, Rebecca
Franzini, Angelo
Messina, Giuseppe
Radu Djurfeldt, Diana
Schechtmann, Gaston
Chen, Long-Long
Eitan, Renata
Israel, Zvi
Bergman, Hagai
Brelje, Tim
Brionne, Thomas C.
Conseil, Aurélie
Gielen, Frans
Schuepbach, Michael
Nuttin, Bart
Gabriëls, Loes
author_role author
author2 Real, Eva
Alonso, Pino
Aparicio, Marco Alberto
Segalàs Cosi, Cinto
Plans, Gerard
Luyten, Laura
Brunfaut, Els
Matthijs, Laurean
Raymakers, Simon
Bervoets, Chris
Higueras, Antonio
Katati, Majed
Guerrero, José
Hurtado, Mariena
Prieto, Mercedes
Stieglitz, Lennart H.
Löffelholz, Georg
Walther, Sebastian
Pollo, Claudio
Zurowski, Bartosz
Tronnier, Volker
Kordon, Andreas
Gambini, Orsola
Ranieri, Rebecca
Franzini, Angelo
Messina, Giuseppe
Radu Djurfeldt, Diana
Schechtmann, Gaston
Chen, Long-Long
Eitan, Renata
Israel, Zvi
Bergman, Hagai
Brelje, Tim
Brionne, Thomas C.
Conseil, Aurélie
Gielen, Frans
Schuepbach, Michael
Nuttin, Bart
Gabriëls, Loes
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Neurosi obsessiva
Estimulació del cervell
Seguretat dels pacients
Obsessive-compulsive disorder
Brain stimulation
Patients safety
topic Neurosi obsessiva
Estimulació del cervell
Seguretat dels pacients
Obsessive-compulsive disorder
Brain stimulation
Patients safety
description Deep brain stimulation (DBS) has been proposed for severe, chronic, treatment-refractory obsessive-compulsive disorder (OCD) patients. Although serious adverse events can occur, only a few studies report on the safety profile of DBS for psychiatric disorders. In a prospective, open-label, interventional multi-center study, we examined the safety and efficacy of electrical stimulation in 30 patients with DBS electrodes bilaterally implanted in the anterior limb of the internal capsule. Safety, efficacy, and functionality assessments were performed at 3, 6, and 12 months post implant. An independent Clinical Events Committee classified and coded all adverse events (AEs) according to EN ISO14155:2011. All patients experienced AEs (195 in total), with the majority of these being mild (52% of all AEs) or moderate (37%). Median time to resolution was 22 days for all AEs and the etiology with the highest AE incidence was 'programming/stimulation' (in 26 patients), followed by 'New illness, injury, condition' (13 patients) and 'pre-existing condition, worsening or exacerbation' (11 patients). Sixteen patients reported a total of 36 serious AEs (eight of them in one single patient), mainly transient anxiety and affective symptoms worsening (20 SAEs). Regarding efficacy measures, Y-BOCS reduction was 42% at 12 months and the responder rate was 60%. Improvements in GAF, CGI, and EuroQol-5D index scores were also observed. In sum, although some severe AEs occurred, most AEs were mild or moderate, transient and related to programming/stimulation and tended to resolve by adjustment of stimulation. In a severely treatment-resistant population, this open-label study supports that the potential benefits outweigh the potential risks of DBS.
publishDate 2019
dc.date.none.fl_str_mv 2019
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/2445/176452
url https://hdl.handle.net/2445/176452
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Reproducció del document publicat a: https://doi.org/10.1038/s41380-019-0562-6
Molecular Psychiatry, 2019, vol. 26, p. 1234-1247
https://doi.org/10.1038/s41380-019-0562-6
dc.rights.none.fl_str_mv cc by (c) Menchón Magriñá, José Manuel et al., 2019
http://creativecommons.org/licenses/by/3.0/es/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv cc by (c) Menchón Magriñá, José Manuel et al., 2019
http://creativecommons.org/licenses/by/3.0/es/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Nature Publishing Group
publisher.none.fl_str_mv Nature Publishing Group
dc.source.none.fl_str_mv Articles publicats en revistes (Ciències Clíniques)
reponame:Dipòsit Digital de la UB
instname:Universidad de Barcelona
instname_str Universidad de Barcelona
reponame_str Dipòsit Digital de la UB
collection Dipòsit Digital de la UB
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869415443053150208
score 15,300724